pipette
ESEspañol

A Global Atlas of Immune Alleles Reveals Health-Relevant Variation Across Groups

W. T. Harvey, A.-K. Emde, F. E. Kakembo, I. Hamid, W. E. Clarke, I. Apriyana, H. Babiker, R. Rakotoarivony, M. Hendershott, P. Kasina, A. Kalungi, O. Ojewunmi, T. Pascart, S. Rosso, R. A. Verdugo, C. Ferreccio, A. Dessein, P. Kusuma, L. Priliani, S. G. Malik, J. Fabian, M. Ramsay, K. A. Wasik, K. Fox, T. R. Merriman, S. Fatumo, H. Sudoyo, L. Yerges-Armstrong, S. E. Castel

PreprintReal-world use

In the authors' words

Immune allele frequencies inform disease association mapping, pharmacogenomic guidance, and vaccine design, yet such data are missing for most of the world's groups. Here we present the Global Atlas of Immune Alleles (GAIA), applying benchmarked genotyping tools across the Human Leukocyte Antigen (HLA), Immunoglobulin Heavy Chain Constant (IGHC), and Fc Gamma Receptor (FCGR) loci to whole-genome sequencing data from 20,248 individuals, oversampling sub-Saharan African, Island Southeast Asian, and Pacific groups. Despite representing fewer than 0.5% of observations in the Allele Frequency Net Database, GAIA expands the database's catalogue by 38%, demonstrating that representation matters more than sample size. We identify HLA alleles at group-specific frequencies that challenge pharmacogenomic screening recommendations and document disease-risk alleles common in groups lacking clinical guidance. Finally, we introduce majority allelic diversity (MAD-X), which counts the alleles required for X% of individuals in a group to carry at least one, and show that reaching 90% HLA-B coverage for vaccine design requires up to 2.7 times more alleles in underrepresented groups than in those of Northwest European ancestry.

Main resultThe abstract does not state a limitation.

In plain words AI summary

The researchers created a database called GAIA that maps immune gene variants across 20,248 people from around the world. These underrepresented groups added 38% more variants to existing databases, even with fewer than 0.5% of global observations. They found immune variants common in specific groups that current medical guidelines miss. Designing vaccines that cover 90% of people requires up to 2.7 times more variants for underrepresented groups than for Northwest Europeans.

Written by Kimi K2.5 using only the abstract above. Jev checked that every sentence is supported by the abstract sentences it cites, and removed any that were not. Point at a sentence to highlight its source. 1 sentence was removed for not being supported by the abstract.

Appeared: Thursday, November 5. medRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.11.02.26367118